Author:
Freudenberg Lutz S.,Jentzen Walter,Stahl Alexander,Bockisch Andreas,Rosenbaum-Krumme Sandra J.
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Reference67 articles.
1. Robbins RJ, Schlumberger MJ. The evolving role of 131I for the treatment of differentiated thyroid carcinoma. J Nucl Med. 2005;46:28S–37S.
2. Riemann B, Krämer JA, Schmid KW, Dralle H, Dietlein M, Schicha H, et al. Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial. Nuklearmedizin. 2010;49(3):79–84.
3. Biermann M, Pixberg M, Riemann B, Schuck A, Heinecke A, Schmid KW, et al. Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer – results after 874 patient-years of follow-up in the MSDS-trial. Nuklearmedizin. 2009;48(3):89–98.
4. Verburg FA, de Keizer B, de Klerk JM, Lentjes EG, Lips CJ, van Isselt JW. Value of diagnostic radioiodine scintigraphy and thyroglobulin measurements after rhTSH injection. Nuklearmedizin. 2009;48(1):26–9.
5. Benua R, Cicale N, Sonenberg M, et al. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. AJR Am J Roentgenol. 1962;87:171–9.
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献